DUBLIN--(BUSINESS WIRE)--The "Gastric Cancer Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global gastric cancer drugs market to grow with a CAGR of 9.5% over the forecast period of 2018-2024.
The report on global gastric cancer drugs market provides qualitative and quantitative analysis for the period of 2016 to 2024.
The report on gastric cancer drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global gastric cancer drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global gastric cancer drugs market over the period of 2016 to 2024. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
The global gastric cancer drugs market is segmented on the basis of route of administration, lines of chemotherapy and molecule type.
Global Gastric Cancer Drugs Market by Route of Administration
Global Gastric Cancer Drugs Market by Lines of Chemotherapy
- First-Line Chemotherapy
- Second-Line Chemotherapy
Global Gastric Cancer Drugs Market by Molecule Type
- Small Molecules
- AROG Pharmaceuticals
- Ipsen Biopharmaceuticals
- Array Biopharma
- Taiho Oncology
- ARIAD Pharmaceuticals
- Eli Lilly
- Galena Biopharma
- ASLAN Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/jx88ng/gastric_cancer?w=4